|
PIK3C2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.99100000000774E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.77149994673442E-09 |
| Normal-vs-Stage2 |
4.311500E-02 |
| Normal-vs-Stage3 |
2.602200E-02 |
| Normal-vs-Stage4 |
7.975800E-01 |
| Stage1-vs-Stage2 |
6.976100E-02 |
| Stage1-vs-Stage3 |
2.194900E-04 |
| Stage1-vs-Stage4 |
3.58850000000688E-05 |
| Stage2-vs-Stage3 |
5.866400E-01 |
| Stage2-vs-Stage4 |
1.041040E-01 |
| Stage3-vs-Stage4 |
1.203170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7567699999943E-05 |
| Normal-vs-AfricanAmerican |
1.319680E-02 |
| Normal-vs-Asian |
1.040040E-01 |
| Caucasian-vs-AfricanAmerican |
5.584200E-01 |
| Caucasian-vs-Asian |
4.204800E-01 |
| AfricanAmerican-vs-Asian |
7.146400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.223800E-04 |
| Normal-vs-Female |
7.34340000030365E-07 |
| Male-vs-Female |
5.304200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.061900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.2176999999447E-06 |
| Normal-vs-Age(61-80Yrs) |
7.418700E-04 |
| Normal-vs-Age(81-100Yrs) |
3.688400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.439000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.753800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.159000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.109600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.725800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.714800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.379200E-03 |
| Normal-vs-Grade 2 |
1.40179999830181E-08 |
| Normal-vs-Grade 3 |
1.460900E-03 |
| Normal-vs-Grade 4 |
6.315400E-01 |
| Grade 1-vs-Grade 2 |
4.188000E-02 |
| Grade 1-vs-Grade 3 |
1.194010E-02 |
| Grade 1-vs-Grade 4 |
2.635800E-03 |
| Grade 2-vs-Grade 3 |
1.882730E-03 |
| Grade 2-vs-Grade 4 |
3.13910000004913E-06 |
| Grade 3-vs-Grade 4 |
5.836400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.80833167621131E-12 |
| Normal-vs-ccB subtype |
1.559200E-01 |
| ccA subtype-vs-ccB subtype |
5.43209999204208E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.011200E-04 |
| Normal-vs-N1 |
4.305800E-01 |
| N0-vs-N1 |
6.770300E-02 |
|
|
